GTHCX
Price
$17.35
Change
+$0.06 (+0.35%)
Updated
Jul 25 closing price
Net Assets
1.16B
JFNIX
Price
$67.37
Change
+$0.24 (+0.36%)
Updated
Jul 25 closing price
Net Assets
4.4B
Interact to see
Advertisement

GTHCX vs JFNIX

Header iconGTHCX vs JFNIX Comparison
Open Charts GTHCX vs JFNIXBanner chart's image
Invesco Health Care C
Price$17.35
Change+$0.06 (+0.35%)
VolumeN/A
Net Assets1.16B
Janus Henderson Global Life Sciences I
Price$67.37
Change+$0.24 (+0.36%)
VolumeN/A
Net Assets4.4B
GTHCX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GTHCX vs. JFNIX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTHCX is a Buy and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.4B vs. GTHCX (1.16B). JFNIX pays higher dividends than GTHCX: JFNIX (0.41) vs GTHCX (0.00). GTHCX was incepted earlier than JFNIX: GTHCX (26 years) vs JFNIX (16 years). GTHCX (1.80) is less costly to investors than JFNIX (0.77). GTHCX is a more actively managed with annual turnover of: 56.00 vs. JFNIX (35.00). GTHCX has a lower initial minimum investment than JFNIX: GTHCX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -14.39 vs. GTHCX (-16.51). JFNIX return over 5 years is better than : 5.22 vs. GTHCX (-37.22).
GTHCXJFNIXGTHCX / JFNIX
Total Expense Ratio1.800.77234%
Annual Report Gross Expense Ratio1.800.77234%
Fund Existence26 years16 years-
Gain YTD1.052-1.308-80%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B4.4B26%
Annual Yield % from dividends0.000.41-
Returns for 1 year-16.51-14.39115%
Returns for 3 years-1.878.97-21%
Returns for 5 years-37.225.22-713%
Returns for 10 years-55.037.40-743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMIDX18.310.19
+1.05%
Brown Advisory Mid-Cap Growth Investor
JGTTX40.99N/A
N/A
JPMorgan Growth Advantage R3
LMRNX33.07N/A
N/A
1919 Socially Responsive Balanced I
MSFLX34.53N/A
N/A
Morgan Stanley Inst Global Franchise L
TRSZX22.64N/A
N/A
T. Rowe Price Mid-Cap Index Z